{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:09:17Z","timestamp":1795028957299,"version":"4.10.2"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.parkreldis.2022.105229","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:49:38Z","timestamp":1669596578000},"page":"105229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-0739","authenticated-orcid":false,"given":"Pietro","family":"La Vitola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Artioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Cerovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Poletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Dacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Leva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5374-3914","authenticated-orcid":false,"given":"Gianluigi","family":"Forloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2022.105229_bib1","first-page":"16018","article-title":"Cognitive decline in Parkinson's disease: the complex picture. Npj Park","volume":"2","author":"Biundo","year":"2016","journal-title":"Dis"},{"key":"10.1016\/j.parkreldis.2022.105229_bib2","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of \u03b1-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2022.105229_bib3","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that -synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.parkreldis.2022.105229_bib4","doi-asserted-by":"crossref","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","article-title":"Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation","volume":"32","author":"Di\u00f3genes","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2022.105229_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07576.x","article-title":"\u03b1-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases: cognitive effects of \u03b1-synuclein oligomers","volume":"120","author":"Martin","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.parkreldis.2022.105229_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mds.26624","article-title":"Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases","volume":"31","author":"Forloni","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.105229_bib7","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1007\/s11064-017-2382-x","article-title":"The oligomer hypothesis in \u03b1-synucleinopathy","volume":"42","author":"Ono","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.parkreldis.2022.105229_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ebiom.2018.01.035","article-title":"Bimolecular fluorescence complementation of alpha-synuclein demonstrates its oligomerization with dopaminergic phenotype in mice","volume":"29","author":"Cai","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.parkreldis.2022.105229_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbi.2018.02.012","article-title":"Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2","volume":"69","author":"La Vitola","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.parkreldis.2022.105229_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/nan.12644","article-title":"Peripheral inflammation exacerbates \u03b1-synuclein toxicity and neuropathology in Parkinson's models","volume":"47","author":"La Vitola","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib11","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from alpha-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.parkreldis.2022.105229_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2022.105229_bib13","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","article-title":"Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production","volume":"74","author":"Tapias","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"295","key":"10.1016\/j.parkreldis.2022.105229_bib14","article-title":"Fibrillar \u03b1-synuclein toxicity depends on functional lysosomes","volume":"18","author":"Guiney","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.parkreldis.2022.105229_bib15","doi-asserted-by":"crossref","first-page":"183776","DOI":"10.1016\/j.bbamem.2021.183776","article-title":"A study on the interaction of the amyloid fibrils of \u03b1-synuclein and hen egg white lysozyme with biological membranes","volume":"1864","author":"Zadali","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.parkreldis.2022.105229_bib16","doi-asserted-by":"crossref","first-page":"41755","DOI":"10.1038\/srep41755","article-title":"Repurposing doxycycline for synucleinopathies: remodelling of \u03b1-synuclein oligomers towards non-toxic parallel beta-sheet structured species","volume":"7","author":"Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2022.105229_bib17","doi-asserted-by":"crossref","first-page":"105256","DOI":"10.1016\/j.nbd.2021.105256","article-title":"Doxycycline inhibits \u03b1-synuclein-associated pathologies in vitro and in vivo","volume":"151","author":"Dominguez-Meijide","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2022.105229_bib18","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1021\/jm400161p","article-title":"A new face for old antibiotics: tetracyclines in treatment of amyloidoses","volume":"56","author":"Stoilova","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.parkreldis.2022.105229_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models","volume":"70","author":"Balducci","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2022.105229_bib20","first-page":"981","article-title":"The neuroprotective effect of doxycycline on neurodegenerative diseases. Neurotox","volume":"35","author":"Santa-Cec\u00edlia","year":"2019","journal-title":"Res."},{"key":"10.1016\/j.parkreldis.2022.105229_bib21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s12035-019-01847-8","article-title":"Neuroprotective effects of doxycycline in the R6\/2 mouse model of huntington's disease","volume":"57","author":"Paldino","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.118.252064","article-title":"Plasma and brain concentrations of doxycycline after single and repeated doses in wild-type and APP23 mice","volume":"368","author":"Lucchetti","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.parkreldis.2022.105229_bib23","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53--> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.parkreldis.2022.105229_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00401-019-02032-w","article-title":"Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of \u03b1-synucleinopathy","volume":"138","author":"Singh","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnagi.2019.00335","article-title":"Early cognitive and behavioral deficits in mouse models for tauopathy and Alzheimer's disease. Front","volume":"11","author":"Samaey","year":"2019","journal-title":"Aging Neurosci"},{"key":"10.1016\/j.parkreldis.2022.105229_bib26","first-page":"2607","article-title":"Assessing burrowing. Nest construction, and hoarding in mice","author":"Deacon","year":"2012","journal-title":"J. Vis. Exp"},{"key":"10.1016\/j.parkreldis.2022.105229_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-018-0271-7","article-title":"Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice","volume":"13","author":"Nardo","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.parkreldis.2022.105229_bib28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.parkreldis.2022.105229_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017953","article-title":"Tauopathic changes in the striatum of A53T \u03b1-synuclein mutant mouse model of Parkinson's disease","volume":"6","author":"Wills","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2022.105229_bib30","doi-asserted-by":"crossref","first-page":"e1118","DOI":"10.1097\/CCM.0000000000001864","article-title":"Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites","volume":"44","author":"Pischiutta","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.parkreldis.2022.105229_bib31","first-page":"901721","article-title":"Gait difficulty, postural instability, and muscle weakness are associated with fear of falling in people with Parkinson's disease","author":"Mak","year":"2012","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.parkreldis.2022.105229_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/awy318","article-title":"Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects","volume":"142","author":"La Vitola","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2022.105229_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","article-title":"Inflammation is genetically implicated in Parkinson's disease","volume":"302","author":"Dzamko","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2022.105229_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/bpa.12371","article-title":"Neuroinflammation in synucleinopathies: neuroinflammation in synucleinopathies","volume":"26","author":"Lim","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1874609810666170315113244","article-title":"Neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer's and Parkinson's diseases","volume":"10","author":"McKenzie","year":"2017","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.parkreldis.2022.105229_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbi.2016.10.012","article-title":"Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by \u03b2-amyloid oligomers in an acute mouse model of Alzheimer's disease","volume":"60","author":"Balducci","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.parkreldis.2022.105229_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","article-title":"Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways","volume":"29","author":"Santa-Cec\u00edlia","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.parkreldis.2022.105229_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1101\/lm.1650110","article-title":"Object recognition memory and the rodent hippocampus","volume":"17","author":"Broadbent","year":"2010","journal-title":"Learn. Mem."},{"key":"10.1016\/j.parkreldis.2022.105229_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneumeth.2014.02.001","article-title":"Burrowing and nest building behavior as indicators of well-being in mice","volume":"234","author":"Jirkof","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.parkreldis.2022.105229_bib41","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3892\/mmr.2014.2563","article-title":"Inflammatory response in Parkinson's disease","volume":"10","author":"Yan","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.parkreldis.2022.105229_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/npp.2016.143","article-title":"Inflammation effects on motivation and motor activity: role of dopamine","volume":"42","author":"Felger","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.parkreldis.2022.105229_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2999(90)90099-R","article-title":"Interleukin-1\u03b2 inhibits long-term potentiation in the CA3 region of mouse hippocampal slices","volume":"181","author":"Katsuki","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(93)90959-Q","article-title":"Interleukin 1\u03b2 inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus","volume":"628","author":"Bellinger","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.parkreldis.2022.105229_bib45","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0896-6273(00)80140-3","article-title":"Martin KC, rose JC, Kandel ER recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF Knockout mice","volume":"16","author":"Patterson","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2022.105229_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(96)01283-8","article-title":"Interleukin-6 inhibits long-term potentiation in rat hippocampal slices","volume":"748","author":"Li","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.parkreldis.2022.105229_bib47","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1523\/JNEUROSCI.18-16-06568.1998","article-title":"Object recognition and location memory in monkeys with excitotoxic lesions of the amygdala and Hippocampus","volume":"18","author":"Murray","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2022.105229_bib48","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1471-4159.2000.0750634.x","article-title":"The inhibitory effects of interleukin-6 on synaptic plasticity in the rat Hippocampus are associated with an inhibition of mitogen-activated protein Kinase ERK","volume":"75","author":"Tancredi","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.parkreldis.2022.105229_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11064-018-2517-8","article-title":"TNF\u03b1 and IL-1\u03b2 but not IL-18 suppresses hippocampal long-term potentiation directly at the synapse","volume":"44","author":"Prieto","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.parkreldis.2022.105229_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8363274","article-title":"Modulation of phospho-CREB by systemically administered recombinant BDNF in the Hippocampus of the R6\/2 mouse model of huntington's disease","volume":"2019","author":"Paldino","year":"2019","journal-title":"Neurosci. J."},{"key":"10.1016\/j.parkreldis.2022.105229_bib51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.pmbts.2020.11.001","article-title":"Inflammation and Parkinson's disease pathogenesis: mechanisms and therapeutic insight","volume":"177","author":"Forloni","year":"2021","journal-title":"Prog Mol Biol Transl Sci."},{"key":"10.1016\/j.parkreldis.2022.105229_bib52","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-\u03b2 oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"62","key":"10.1016\/j.parkreldis.2022.105229_bib53","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3233\/JAD-170819","article-title":"Alzheimer's disease, oligomers, and inflammation. J","volume":"2018","author":"Forloni","year":"2018","journal-title":"Alzheimers Dis"},{"key":"10.1016\/j.parkreldis.2022.105229_bib54","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson's disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib55","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"3","author":"Ha\u00efk","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/19336896.2015.1027857","article-title":"Preventive study in subjects at risk of fatal familial insomnia: innovative approach to rare diseases","volume":"9","author":"Forloni","year":"2015","journal-title":"Prion"},{"key":"10.1016\/j.parkreldis.2022.105229_bib57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2022.105229_bib58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbr.2007.07.026","article-title":"Perirhinal cortex damage and anterograde object-recognition in rats after long retention intervals","volume":"185","author":"Mumby","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.parkreldis.2022.105229_bib59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2014.08.002","article-title":"Assessing rodent hippocampal involvement in the novel object recognition task. A review","volume":"285","author":"Cohen","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.parkreldis.2022.105229_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200809","article-title":"Prefrontal cortex-dependent innate behaviors are altered by selective knockdown of Gad1 in neuropeptide Y interneurons","volume":"13","author":"Corder","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2022.105229_bib61","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1096\/fj.201901984R","article-title":"BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease","volume":"34","author":"Wu","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.parkreldis.2022.105229_bib62","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The lewy body in Parkinson's disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.105229_bib63","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.parkreldis.2022.105229_bib64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5607\/en.2016.25.3.113","article-title":"Non-cell-autonomous neurotoxicity of \u03b1-synuclein through microglial toll-like receptor 2","volume":"25","author":"Kim","year":"2016","journal-title":"Exp. Neurobiol."},{"issue":"9","key":"10.1016\/j.parkreldis.2022.105229_bib65","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1523\/JNEUROSCI.4977-09.2010","article-title":"Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration","volume":"30","author":"Tsika","year":"2010","journal-title":"he Journal of Neuroscience"},{"key":"10.1016\/j.parkreldis.2022.105229_bib67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.parkreldis.2022.105229_bib68","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1093\/brain\/awx275","article-title":"Synaptic phosphorylated \u03b1-synuclein in dementia with Lewy bodies","volume":"140","author":"Colom-Cadena","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2022.105229_bib66","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/glia.22372","article-title":"Microglia as modulators of cognition and neuropsychiatric disorders","volume":"61","author":"Blank","year":"2013","journal-title":"Glia"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022003984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022003984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:26:43Z","timestamp":1761179203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802022003984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":68,"alternative-id":["S1353802022003984"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.105229","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.105229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105229"}}